MOLTENI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.969
EU - Europa 1.854
AS - Asia 822
SA - Sud America 51
AF - Africa 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.707
Nazione #
US - Stati Uniti d'America 2.928
IT - Italia 643
DE - Germania 357
SG - Singapore 347
CN - Cina 182
IE - Irlanda 167
SE - Svezia 138
RU - Federazione Russa 117
AT - Austria 87
HK - Hong Kong 83
GB - Regno Unito 79
ID - Indonesia 64
BR - Brasile 47
IN - India 46
UA - Ucraina 46
FI - Finlandia 41
VN - Vietnam 41
CA - Canada 40
DK - Danimarca 30
ES - Italia 29
BE - Belgio 28
FR - Francia 26
PL - Polonia 16
KR - Corea 14
CH - Svizzera 12
JP - Giappone 12
TR - Turchia 11
NL - Olanda 10
CZ - Repubblica Ceca 8
IR - Iran 6
RO - Romania 6
TW - Taiwan 6
BG - Bulgaria 5
EG - Egitto 5
EE - Estonia 3
NZ - Nuova Zelanda 3
AR - Argentina 2
HU - Ungheria 2
MY - Malesia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
LT - Lituania 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 5.707
Città #
Ann Arbor 1.022
Frankfurt am Main 296
Chandler 254
Singapore 254
Wilmington 209
Milan 183
Dublin 162
Woodbridge 161
Fairfield 144
Ashburn 96
Dearborn 83
Hong Kong 82
New York 81
Vienna 81
Houston 73
Seattle 65
Jakarta 64
Princeton 58
Santa Clara 55
Cambridge 51
Jacksonville 43
Nanjing 32
Helsinki 30
Rome 30
Shanghai 30
London 28
Brussels 25
Granada 24
Council Bluffs 23
Pune 23
Fremont 18
Lawrence 17
Nuremberg 16
Guangzhou 15
Altamura 14
Los Angeles 14
Monza 13
Romola 13
Toronto 12
San Diego 11
Andover 10
Boardman 10
Carate Brianza 10
Beijing 9
Kunming 9
Nanchang 9
Tokyo 9
Dong Ket 8
Hangzhou 8
Hebei 8
Lachine 8
Sacramento 8
Edmonton 7
Shenyang 7
Bari 6
Chiavari 6
Falls Church 6
Melzo 6
Munich 6
Radomsko 6
Turin 6
Arcore 5
Bergamo 5
Bresso 5
Brno 5
Chicago 5
Durham 5
Kiev 5
Napoli 5
Pavia 5
São Paulo 5
Zurich 5
Assago 4
Bolzano 4
Bonndorf 4
Cagliari 4
Como 4
Jinan 4
Lecco 4
Norwalk 4
Ottawa 4
Padova 4
Piemonte 4
Plovdiv 4
Ropczyce 4
Seregno 4
Taizhou 4
Thunder Bay 4
Tianjin 4
Ancona 3
Auburn 3
Auckland 3
Brescia 3
Cardito 3
Carobbio degli Angeli 3
Changsha 3
Cologno 3
Cormano 3
Elora 3
Falkenstein 3
Totale 4.223
Nome #
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 366
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 353
Growth hormone secretagogues and the regulation of calcium signaling in muscle 330
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 320
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 295
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 284
PHARMACOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR SIGNALLING PATHWAY ACTIVATED BY TLQP-21 262
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 259
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 242
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 237
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 222
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 214
Parma consensus statement on metabolic disruptors 207
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 196
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 191
TLQP-21 modulate inflammation and fibrosis in a model of ards 187
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 155
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 145
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 139
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 139
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 138
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 137
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 128
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 110
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 97
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 96
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 77
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 75
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 69
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 62
null 57
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 57
The Role of NMNAT2/SARM1 in Neuropathy Development 54
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 37
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 32
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 29
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 22
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 18
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 17
Role of nutrition in degenerative disease 6
Totale 6.061
Categoria #
all - tutte 20.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020225 0 0 0 0 0 0 0 0 80 70 53 22
2020/20211.008 42 43 97 97 72 101 83 90 87 85 99 112
2021/2022656 91 71 56 52 37 44 22 21 24 58 58 122
2022/20231.122 130 252 140 116 56 172 21 79 75 17 33 31
2023/2024726 26 39 41 53 76 202 121 28 42 13 14 71
2024/20251.080 96 132 119 121 158 120 167 62 105 0 0 0
Totale 6.061